Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:17 AM
Ignite Modification Date:
2025-12-25 @ 3:17 AM
NCT ID:
NCT03983005
Eligibility Criteria:
Inclusion Criteria:
* Adult patients with a lung parenchymal lesion suspected for malignancy, in contact or adjacent to the esophagus at the CT scan (with or without mediastinal lymph adenopathies), requiring a pathological diagnosis:
* which can not be sample by bronchoscopy/EBUS-TBNA or
* with a previous not diagnostic bronchoscopy/EBUS-TBNA or
* with clinical/anesthesiological contraindications to bronchoscopy/EBUS-TBNA or
* with a previous nodal EUS-B-FNA not diagnostic/not adequate at the ROSE
* Patients with lung parenchymal lesions who are able to sign the informed consent for the study participation
Exclusion Criteria:
* Patients with lung parenchymal lesions of known etiology;
* Patients with lung parenchymal lesions in whom bronchoscopic ultrasound-guided trans- esophageal needle aspiration is contraindicated;
* Patients with lung parenchymal lesions who refuse/are not able to sign the informed consent for the study participation
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03983005
Study Brief:
Protocol Section:
NCT03983005